Dynavax Technologies
DVAX
#4927
Rank
ยฃ1.32 B
Marketcap
ยฃ11.32
Share price
0.03%
Change (1 day)
6.58%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -ยฃ27.93 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are ยฃ0.33 Billion. In 2024 the company made an earning of ยฃ27.51 Million, an increase over its 2023 earnings that were of ยฃ1.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ27.93 Million-201.49%
2024 ยฃ27.51 M1475.31%
2023 ยฃ1.74 M-99.2%
2022 ยฃ0.21 B238.78%
2021 ยฃ64.81 M-257.89%
2020 -ยฃ41.06 Million-58.58%
2019 -ยฃ99.11 Million-9.32%
2018 -ยฃ0.11 Billion60.44%
2017 -ยฃ68.12 Million-15.8%
2016 -ยฃ80.9 Million4.22%
2015 -ยฃ77.62 Million16.54%
2014 -ยฃ66.61 Million37.09%
2013 -ยฃ48.59 Million
2010 -ยฃ34.78 Million214.85%
2009 -ยฃ11.05 Million-37.33%
2008 -ยฃ17.63 Million-66.07%
2007 -ยฃ51.95 Million16.92%
2006 -ยฃ44.43 Million170.36%
2005 -ยฃ16.44 Million33.39%
2004 -ยฃ12.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.66 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.02 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.39 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.22 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.87 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.56 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ6.81 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
ยฃ15.09 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.29 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel